Foresee Pharmaceuticals Co., Ltd.

Foresee Pharmaceuticals Co., Ltd.verified

6576.TWO

Price:

$78.5

Market Cap:

$12.36B

Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company's stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pul...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2016-04-12

Stock Exchange

TWO

Ticker

6576.TWO

The PE Ratio as of December 2025 (TTM) for Foresee Pharmaceuticals Co., Ltd. (6576.TWO) is -9.46

According to Foresee Pharmaceuticals Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -9.46. This represents a change of -25.87% compared to the average of -12.76 of the last 4 quarters.

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) Historical PE Ratio (quarterly & annually)

How has 6576.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Foresee Pharmaceuticals Co., Ltd. over the last ten years is -16.30. The current -9.46 PE Ratio has changed 5.71% with respect to the historical average. Over the past ten years (40 quarters), 6576.TWO's PE Ratio was at its highest in in the December 2024 quarter at -5.50. The PE Ratio was at its lowest in in the March 2024 quarter at -27.84.

Quarterly (TTM)
Annual

Average

-16.30

Median

-14.78

Minimum

-24.63

Maximum

-9.84

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Foresee Pharmaceuticals Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 59.19%

Maximum Annual PE Ratio = -9.84

Minimum Annual Increase = -47.87%

Minimum Annual PE Ratio = -24.63

Quarterly (TTM)
Annual
YearPE RatioChange
2024-9.84-16.34%
2023-11.77-47.87%
2022-22.57-8.38%
2021-24.6338.49%
2020-17.7959.19%

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) Average PE Ratio

How has 6576.TWO PE Ratio performed in the past?

The current PE Ratio of Foresee Pharmaceuticals Co., Ltd. (6576.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-14.73

5-year avg

-17.32

10-year avg

-16.30

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) PE Ratio vs. Peers

How is 6576.TWO’s PE Ratio compared to its peers?

Foresee Pharmaceuticals Co., Ltd.’s PE Ratio is less than ScinoPharm Taiwan, Ltd. (71.28), less than Standard Chem & Pharm Co. Ltd. (12.05), less than Universal Vision Biotechnology Co., Ltd. (12.40), greater than Medeon Biodesign, Inc. (-11.52), greater than Medigen Vaccine Biologics Corporation (-73.18), less than Visco Vision Inc. (15.70), less than United Orthopedic Corporation (19.89), less than YungShin Global Holding Corporation (15.94), less than TaiDoc Technology Corporation (8.01), less than TaiDoc Technology Corporation (8.01),

Build a custom stock screener for Foresee Pharmaceuticals Co., Ltd. (6576.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Foresee Pharmaceuticals Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Foresee Pharmaceuticals Co., Ltd. (6576.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Foresee Pharmaceuticals Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Foresee Pharmaceuticals Co., Ltd.'s PE Ratio?

How is the PE Ratio calculated for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?

What is the highest PE Ratio for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?

What is the 3-year average PE Ratio for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?

What is the 5-year average PE Ratio for Foresee Pharmaceuticals Co., Ltd. (6576.TWO)?

How does the current PE Ratio for Foresee Pharmaceuticals Co., Ltd. (6576.TWO) compare to its historical average?